Christophe Ullmann

This inventor holds 7 USPTO granted patents and 2 published patent applications, plus 5 CIPO patents and 6 EPO patents. Top assignees: IFP Energies Nouvelles, Proteus Gmbh, Centre National De La Recherche Scientifique. Active years: 2016-2025.

USPTO Granted Patents = 7 (Patent Applications = 2)

% Patents Active = 100.0

CIPO Patents = 5

EPO Patents = 6 (Patent Applications = 8)

Average Co-Inventor Count = 6.2

ph-index = 1

Company Filing History:

6 out of 1,198

IFP Energies Nouvelles

Centre National De La Recherche Scientifique

where one patent can have more than one assignee

Years Active: 2016-2025

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12416027 - Squalene hopene cyclase (SHC) variants (2025-09-16),

2. 11286472 - Variants of exoglucanases having improved activity and uses thereof (2022-03-29),

3. 10745679 - Variants of exoglucanases having improved activity and uses thereof (2020-08-18),

4. 10738291 - Variants of exoglucanases having improved activity and uses thereof (2020-08-11),

5. 10000780 - Endoglucanase variants having improved activity, and uses of same (2018-06-19),

6. 9920308 - Endoglucanase variants having improved activity, and uses of same (2018-03-20),

7. 9382555 - Polypetide with enhanced beta-glucosidase activity at low temperature (2016-07-05),

Title: Christophe Ullmann: Innovator in Enzyme Technology

Introduction

Christophe Ullmann is a prominent inventor based in Nimes, France. He has made significant contributions to the field of enzyme technology, holding a total of seven patents. His work focuses on the optimization and application of enzymes for various industrial processes.

Latest Patents

Ullmann's latest patents include innovations such as Squalene hopene cyclase (SHC) variants. These SHC enzymes and their variants are utilized for producing (−)-Ambrox from homofarnesol and Ambra oxide from bishomofarnesol. Another notable patent involves variants of exoglucanases that exhibit improved activity. This invention relates to the expression and optimization of enzymes that break down lignocellulosic biomass, enhancing efficiency in cellulose breakdown and biofuel production.

Career Highlights

Throughout his career, Ullmann has worked with notable companies, including Ifp Energies Nouvelles and Proteus GmbH. His expertise in enzyme technology has positioned him as a key player in the development of sustainable solutions for energy and materials.

Collaborations

Ullmann has collaborated with esteemed colleagues such as Cecile Persillon and Celine Ayrinhac. These partnerships have furthered his research and innovation in the field of enzyme applications.

Conclusion

Christophe Ullmann's contributions to enzyme technology and his innovative patents highlight his role as a leading inventor in the industry. His work continues to influence advancements in biofuel production and sustainable practices.